| Q52656068 | A Comprehensive Analysis of Argonaute-CLIP Data Identifies Novel, Conserved and Species-Specific Targets of miR-21 in Human Liver and Hepatocellular Carcinoma. |
| Q24633772 | A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion |
| Q24629145 | An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma |
| Q39036472 | Clinical significance and detection of microRNA-21 in serum of patients with diffuse large B-cell lymphoma in Chinese population |
| Q38034755 | Current Progress on Understanding MicroRNAs in Glioblastoma Multiforme |
| Q38858984 | DEAD-box RNA helicase DDX23 modulates glioma malignancy via elevating miR-21 biogenesis |
| Q37285274 | DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients |
| Q42965863 | Deletion of PTENP1 pseudogene in human melanoma |
| Q84755402 | Dendrimer-Based Drug Delivery Systems for Brain Targeting |
| Q39281860 | Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells. |
| Q39125495 | Expression and significance of miRNA-21 and BTG2 in lung cancer |
| Q38777383 | Extracellular Vesicles and MicroRNAs: Their Role in Tumorigenicity and Therapy for Brain Tumors |
| Q34613149 | Feedback regulations of miR-21 and MAPKs via Pdcd4 and Spry1 are involved in arsenite-induced cell malignant transformation |
| Q35639929 | Global expression analysis identified a preferentially nerve growth factor-induced transcriptional program regulated by sustained mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) and AP-1 protein activation during PC12 ce |
| Q28389846 | Identification of a core miRNA-pathway regulatory network in glioma by therapeutically targeting miR-181d, miR-21, miR-23b, β-Catenin, CBP, and STAT3 |
| Q28484310 | Identifying mRNA, microRNA and protein profiles of melanoma exosomes |
| Q34584599 | Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer |
| Q53181228 | KRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma. |
| Q61808203 | Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2 |
| Q38998624 | Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells. |
| Q55284142 | Long non-coding RNA GAS5 inhibits ovarian cancer cell proliferation via the control of microRNA-21 and SPRY2 expression. |
| Q39420627 | MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2. |
| Q46677764 | MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas. |
| Q34323121 | MiR-21 simultaneously regulates ERK1 signaling in HSC activation and hepatocyte EMT in hepatic fibrosis |
| Q36915053 | MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas |
| Q41208796 | MicroRNA Regulation of Glycolytic Metabolism in Glioblastoma. |
| Q38770220 | MicroRNA and extracellular vesicles in glioblastoma: small but powerful |
| Q34409620 | MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview. |
| Q37420580 | MicroRNA in Human Glioma |
| Q55457054 | MicroRNA-1231 exerts a tumor suppressor role through regulating the EGFR/PI3K/AKT axis in glioma. |
| Q39147138 | MicroRNA-21 promotes the proliferation and inhibits apoptosis in Eca109 via activating ERK1/2/MAPK pathway |
| Q37620693 | MicroRNA-21 regulates T-cell apoptosis by directly targeting the tumor suppressor gene Tipe2. |
| Q41461370 | MicroRNA-27b inhibits Spry2 expression and promotes cell invasion in glioma U251 cells |
| Q46190130 | MicroRNA-target cross-talks: Key players in glioblastoma multiforme |
| Q37897499 | MicroRNAs as regulators of neural stem cell-related pathways in glioblastoma multiforme |
| Q38018097 | MicroRNAs as therapeutic targets and their potential applications in cancer therapy |
| Q47994022 | MicroRNAs in Breast Cancer: Diagnostic and Therapeutic Potential. |
| Q26747273 | MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics |
| Q37974078 | MicroRNAs in neural cell development and brain diseases |
| Q34750470 | Microarray and deep sequencing cross-platform analysis of the mirRNome and isomiR variation in response to epidermal growth factor |
| Q34097621 | PTEN modulates miR-21 processing via RNA-regulatory protein RNH1. |
| Q50965411 | Pilocytic astrocytomas of the optic nerve and their relation to pilocytic astrocytomas elsewhere in the central nervous system. |
| Q59333218 | Potential Epigenetic-Based Therapeutic Targets for Glioma |
| Q37335617 | Prioritizing cancer-related microRNAs by integrating microRNA and mRNA datasets |
| Q38929251 | Prognostic role of microRNA-21 expression in gliomas: a meta-analysis |
| Q38898532 | Proteomic screening and identification of microRNA-128 targets in glioma cells |
| Q21135142 | Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme |
| Q55462054 | Recent innovations in the management of low-grade gliomas. |
| Q33727024 | Roles of Long Non-Coding RNAs on Tumorigenesis and Glioma Development |
| Q48258004 | Signaling pathways and mesenchymal transition in pediatric high-grade glioma. |
| Q34450866 | Silencing of microRNA-21 confers radio-sensitivity through inhibition of the PI3K/AKT pathway and enhancing autophagy in malignant glioma cell lines |
| Q89619715 | Simultaneous Knockdown of Sprouty2 and PTEN Promotes Axon Elongation of Adult Sensory Neurons |
| Q36897123 | Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL. |
| Q36371890 | Sprouty2 Drives Drug Resistance and Proliferation in Glioblastoma. |
| Q37706271 | Sprouty2 correlates with favorable prognosis of gastric adenocarcinoma via suppressing FGFR2-induced ERK phosphorylation and cancer progression |
| Q52720290 | Sprouty2 enhances the tumorigenic potential of glioblastoma cells. |
| Q38396518 | Sprouty2 is associated with prognosis and suppresses cell proliferation and invasion in renal cell carcinoma |
| Q92372490 | Sprouty3 and Sprouty4, Two Members of a Family Known to Inhibit FGF-Mediated Signaling, Exert Opposing Roles on Proliferation and Migration of Glioblastoma-Derived Cells |
| Q91599145 | The Role of Circulating MicroRNA in Glioblastoma Liquid Biopsy |
| Q52670829 | The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug. |
| Q41134742 | The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL |
| Q38802129 | Upregulation of microRNA‑27b contributes to the migration and invasion of gastric cancer cells via the inhibition of sprouty2‑mediated ERK signaling |
| Q39392869 | Ursolic acid inhibits proliferation and induces apoptosis in human glioblastoma cell lines U251 by suppressing TGF-β1/miR-21/PDCD4 pathway |
| Q36127410 | VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signaling |
| Q36464776 | miR-21 expression predicts prognosis in diffuse large B-cell lymphoma |
| Q60929807 | miR-23a promotes invasion of glioblastoma HOXD10-regulated glial-mesenchymal transition |
| Q38824458 | miRNA-182 and the regulation of the glioblastoma phenotype - toward miRNA-based precision therapeutics |
| Q38092617 | miRNA-Based Therapeutic Strategies |
| Q88477804 | microRNA-21 Confers Neuroprotection Against Cerebral Ischemia-Reperfusion Injury and Alleviates Blood-Brain Barrier Disruption in Rats via the MAPK Signaling Pathway |
| Q39327988 | microRNA-21 is upregulated in malignant melanoma and influences apoptosis of melanocytic cells |
| Q38904937 | p16(INK4A) inhibits the pro-metastatic potentials of osteosarcoma cells through targeting the ERK pathway and TGF-β1. |